Compare Illumina, Inc. (ILMN) vs Roblox Corp (RBLX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Illumina, Inc. vs Roblox Corp — how do they compare? Illumina, Inc. trades at $189.99 (market cap $27.94B), while Roblox Corp trades at $53.2 (market cap $38.13B). The key difference: Roblox Corp is the larger of the two by market cap, and Illumina, Inc. is trading nearer its 52-week high, Roblox Corp nearer its low. Which is the better fit depends on your goals.
| ILMN | RBLX | |
|---|---|---|
Market Cap | $27.94B | $38.13B |
Sector | Health | Media |
52-Week High | $194.33 | $141.56 |
52-Week Low | $91.00 | $41.30 |
Enterprise Value | $29.33B | $36.71B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Illumina (ILMN) trades at $185.36, down 0.69% on the day, with a bullish technical signal from moving averages. The stock shows strong profitability with a 19.42% net income margin and has beaten EPS estimates for three consecutive quarters. Recent news highlights expansion of the Billion Cell Atlas program and upcoming Q2 2026 earnings on July 30.
Outlook remains positive with 51% analyst buy ratings, though the current price exceeds the $178 consensus target. Key risks include competitive pressure from Roche's new sequencer and China market weakness. Earnings growth and cost control initiatives support upside potential, but valuation multiples suggest limited near-term appreciation.
Roblox trades at $54.08, up 4.64% today, showing positive momentum despite a bearish technical signal. The company continues to demonstrate strong revenue growth with $4.89B in 2025, though it remains unprofitable with a -20.69% net margin. Recent product innovation includes the launch of 'Build,' an AI-powered game creation tool, while facing multiple class-action lawsuits alleging securities fraud between October 2025 and April 2026.
While analyst consensus remains positive with a $59.62 price target and 51% buy ratings, investors face significant risks from ongoing litigation and persistent profitability challenges. The stock's high P/B ratio of 85.65 suggests premium valuation despite negative returns on equity, creating a mixed investment case dependent on future margin improvement.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Illumina, Inc.
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (less than 10% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
Read more on ILMN →About Roblox Corp
Roblox operates an online video game platform that lets young gamers create, develop, and monetize games (or experiences) for other players. The firm effectively offers its developers a hybrid of a game engine, publishing platform, online hosting and services, marketplace with payment processing, and social network. The platform is a closed garden that Roblox controls, earning revenue in multiple places while benefiting from outsourced game development. Unlike traditional video game publishers, Roblox is more focused on the creation of new tools and monetization techniques for its developers then creating new games or franchises. Roblox is increasingly focused on creating a metaverse that moves beyond games toward experiences like concerts, education, and even business management.
Read more on RBLX →
